Is Iovance Biotherapeutics, Inc. (IOVA) a Buy, Sell, or Hold?
NASDAQ : IOVA
Iovance Biotherapeutics, Inc.
$4.74 USD
$0.81 (20.61%)
- Volume
- 43.43M
- Average Volume
- 14.22M
- Market Capitalization
- $1.69B
- P/E Ratio
- -5.15
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $5.63
- Year Low
- $1.76
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.60
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
43
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
66
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$1.01M
IOVA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
IOVA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| WEISER MICHAEL | director | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Dukes Iain D. | director | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Countouriotis Athena | director | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Maynard Ryan D | director | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-06-16 | A-Award | 0 | 2026-06-18 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-06-05 | M-Exempt | 0 | 2026-06-09 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-06-05 | F-InKind | 4.23 | 2026-06-09 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-06-05 | M-Exempt | 0 | 2026-06-09 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-06-05 | M-Exempt | 0 | 2026-06-09 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-06-05 | F-InKind | 4.23 | 2026-06-09 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-06-05 | M-Exempt | 0 | 2026-06-09 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-06-05 | M-Exempt | 0 | 2026-06-09 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-06-05 | F-InKind | 4.23 | 2026-06-09 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-06-05 | M-Exempt | 0 | 2026-06-09 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-06-05 | M-Exempt | 0 | 2026-06-09 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-06-05 | F-InKind | 4.23 | 2026-06-09 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-06-05 | M-Exempt | 0 | 2026-06-09 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-06-01 | F-InKind | 3.96 | 2026-06-03 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-06-01 | F-InKind | 3.96 | 2026-06-03 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-06-01 | F-InKind | 3.96 | 2026-06-03 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-06-01 | F-InKind | 3.96 | 2026-06-03 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-05-11 | M-Exempt | 0 | 2026-05-13 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-05-11 | F-InKind | 3.7 | 2026-05-13 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-05-11 | M-Exempt | 0 | 2026-05-13 |
| Roche Corleen M. | officer: Chief Financial Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-03-05 | M-Exempt | 0 | 2026-03-06 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-03-05 | F-InKind | 4.58 | 2026-03-06 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-03-05 | M-Exempt | 0 | 2026-03-06 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-03-05 | M-Exempt | 0 | 2026-03-06 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-03-05 | F-InKind | 4.58 | 2026-03-06 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-03-05 | M-Exempt | 0 | 2026-03-06 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-03-05 | M-Exempt | 0 | 2026-03-06 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-03-05 | F-InKind | 4.58 | 2026-03-06 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-03-05 | M-Exempt | 0 | 2026-03-06 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-03-05 | M-Exempt | 0 | 2026-03-06 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-03-05 | F-InKind | 4.58 | 2026-03-06 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-03-05 | M-Exempt | 0 | 2026-03-06 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-03-02 | F-InKind | 3.79 | 2026-03-04 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-03-02 | F-InKind | 3.79 | 2026-03-04 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-03-02 | F-InKind | 3.79 | 2026-03-04 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-03-02 | F-InKind | 3.79 | 2026-03-04 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2026-03-02 | M-Exempt | 0 | 2026-03-04 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-02-24 | M-Exempt | 0 | 2026-02-26 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-02-24 | F-InKind | 3.78 | 2026-02-26 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-02-24 | M-Exempt | 0 | 2026-02-26 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-02-10 | M-Exempt | 0 | 2026-02-12 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-02-10 | M-Exempt | 0 | 2026-02-12 |
| Kirby Daniel Gordon | officer: Chief Commercial Officer | 2026-02-10 | F-InKind | 2.6 | 2026-02-12 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2025-12-01 | M-Exempt | 0 | 2025-12-03 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2025-12-02 | M-Exempt | 0 | 2025-12-03 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2025-12-02 | F-InKind | 2.14 | 2025-12-03 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2025-12-01 | F-InKind | 2.23 | 2025-12-03 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2025-12-01 | M-Exempt | 0 | 2025-12-03 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2025-12-02 | M-Exempt | 0 | 2025-12-03 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2025-12-01 | M-Exempt | 0 | 2025-12-03 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2025-12-02 | M-Exempt | 0 | 2025-12-03 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2025-12-02 | F-InKind | 2.14 | 2025-12-03 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2025-12-01 | F-InKind | 2.23 | 2025-12-03 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2025-12-01 | M-Exempt | 0 | 2025-12-03 |
| BILINSKY IGOR | officer: Chief Operating Officer | 2025-12-02 | M-Exempt | 0 | 2025-12-03 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-12-01 | M-Exempt | 0 | 2025-12-03 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-12-02 | M-Exempt | 0 | 2025-12-03 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-12-02 | F-InKind | 2.14 | 2025-12-03 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-12-01 | F-InKind | 2.23 | 2025-12-03 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-12-01 | M-Exempt | 0 | 2025-12-03 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-12-02 | M-Exempt | 0 | 2025-12-03 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2025-12-01 | M-Exempt | 0 | 2025-12-03 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2025-12-01 | F-InKind | 2.23 | 2025-12-03 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2025-12-01 | M-Exempt | 0 | 2025-12-03 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-09-02 | M-Exempt | 0 | 2025-09-04 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-09-02 | F-InKind | 2.19 | 2025-09-04 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-09-02 | M-Exempt | 0 | 2025-09-04 |
| Vogt Frederick G | director, officer: Interim CEO & General Counsel | 2025-09-02 | M-Exempt | 0 | 2025-09-04 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2025-09-02 | M-Exempt | 0 | 2025-09-04 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2025-09-02 | F-InKind | 2.19 | 2025-09-04 |
| Puri Raj K. | officer: Chief Regulatory Officer | 2025-09-02 | M-Exempt | 0 | 2025-09-04 |
| GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | 2025-09-02 | M-Exempt | 0 | 2025-09-04 |